Home
Conditions
Hodgkin Lymphoma

Clinical trial condition

Hodgkin Lymphoma

Explore clinical trials studying Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

235 public trials 61 recruiting studies

Refine in advanced search Browse all conditions

Hodgkin Lymphoma trial results

Completed

Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk

NCT03436862

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +10 more
Locations: Colorado Blood Cancer Institute Denver, Colorado, United States

HCA Midwest Kansas City, Missouri, United States

Tennessee Oncology Nashville, Tennessee, United States

St. David's South Austin Medical Center Austin, Texas, United States

View Trial Details

Completed

Brentuximab for Newly Diagnosed Hodgkin Disease

NCT02398240

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: New York Medical College Valhalla, New York, United States

View Trial Details

Completed

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

NCT03096782

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia, +59 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Combination of Nivolumab and DHAP in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (Nivo-DHAP)

NCT04091490

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: The Federal Budget-Funded Institution National Medical Surgical Center named after N. I. Pirogov of the Ministry of health of the Russian Federation Moscow, Russia

View Trial Details

Completed

Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies

NCT04748185

Conditions: B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, +21 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Detection and Characterization of Residual Masses in Lymphomas

NCT02300402

Conditions: B-cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
Locations: Hopital Henri Mondor Créteil, France

View Trial Details

Completed

Improving Exercise Capacity With Tailored Physical Activity in Lymphoma & Breast Cancer Patients Undergoing Tx

NCT03923504

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
Locations: Virginia Commonwealth University Massey Cancer Center Richmond, Virginia, United States

Virginia Commonwealth University Community Memorial Health Center South Hill, Virginia, United States

View Trial Details

Completed

Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803

NCT02890758

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma of Rectum, +65 more
Locations: University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT

NCT04629430

Conditions: Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, +42 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies

NCT01947140

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +44 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Columbia University Irving Medical Center New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Hodgkin Lymphoma

Hodgkin Lymphoma trial results

Related conditions